95332-26-6 (2-羟基-4-(甲氧基甲氧基)苯甲醛,Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-)

CAS号:
95332-26-6
中文名称:
2-羟基-4-(甲氧基甲氧基)苯甲醛
英文名称:
Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-
分子式:
C9H10O4
分子量:
182.173303127289

2-羟基-4-(甲氧基甲氧基)苯甲醛(95332-26-6)名称与标识符

名称

中文别名:
2-羟基-4-(甲氧基甲氧基)苯甲醛;
英文别名:
Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-;2-hydroxy-4-(methoxymethoxy)Benzaldehyde;2-Hydroxy-4-(methoxymethoxy)benzaldehyde (ACI);2-Hydroxy-4-(methoxymethyloxy)benzaldehyde;2-Hydroxy-4-methoxymethoxybenzaldehyde;4-(Methoxymethoxy)salicylaldehyde;797JEB8UWT;CHEMBL1883324;2,4-dihydroxybenzaldehyde 4-methoxymethyl ether;starbld0019360;2-Hydroxy-4-methoxymethyloxy-benzaldehyde;DA-26133;AKOS004902670;HMS2269P22;95332-26-6;E85387;DTXSID80373067;SCHEMBL1960093;SMR000470950;MFCD06661069;MLS000697616;CS-0196259;L023982;VYLBFPQDUSNVCA-UHFFFAOYSA-N;

标识符

MDL:
MFCD06661069
InChIKey:
VYLBFPQDUSNVCA-UHFFFAOYSA-N
Inchi:
1S/C9H10O4/c1-12-6-13-8-3-2-7(5-10)9(11)4-8/h2-5,11H,6H2,1H3
SMILES:
O=CC1C(O)=CC(OCOC)=CC=1

2-羟基-4-(甲氧基甲氧基)苯甲醛(95332-26-6)物化性质

计算特性

  • 精确分子量 : 182.05790880g/mol
  • 氢键供体数量 : 1
  • 氢键受体数量 : 4
  • 可旋转化学键数量 : 4
  • 同位素质量 : 182.05790880g/mol
  • 重原子数量 : 13
  • 复杂度 : 160
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.5
  • 拓扑分子极性表面积 : 55.8Ų

2-羟基-4-(甲氧基甲氧基)苯甲醛(95332-26-6)推荐厂家 更多厂家(5)

公司名称手机号/电话联系人QQ微信询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单

2-羟基-4-(甲氧基甲氧基)苯甲醛(95332-26-6)合成路线

合成路线:1 步
反应条件:
参考文献:
Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ Agonists
Rikimaru, Kentaro; Wakabayashi, Takeshi; Abe, Hidenori; Tawaraishi, Taisuke; Imoto, Hiroshi; et al, Bioorganic & Medicinal Chemistry, 2012, 20(10), 3332-3358
合成路线:1 步
反应条件:
参考文献:
The first total synthesis of phebaclavin A and C
Zhang, Yu; Liu, Dong; Li, Yang; Cao, Xiao-Ping, Chinese Journal of Chemistry, 2005, 23(10), 1453-1456
合成路线:1 步
反应条件:
参考文献:
Synthesis of 6-methoxy-1-oxaspiro[4.5]deca-6,9-dien-8-one
Plourde, Guy L.; Fisher, Benjamin B., Molecules [online computer file], 2002, 7(2), 315-319
合成路线:1 步
反应条件:
参考文献:
Tandem Claisen Rearrangement/6-endo Cyclization Approach to Allylated and Prenylated Chromones
Schmidt, Bernd; Riemer, Martin; Schilde, Uwe, European Journal of Organic Chemistry, 2015, 2015(34), 7602-7611
合成路线:1 步
反应条件:
参考文献:
Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B
Wang, Zengtao; Liu, Zhiguo; Lee, Woojung; Kim, Su-Nam; Yoon, Goo; et al, Bioorganic & Medicinal Chemistry Letters, 2014, 24(15), 3337-3340
合成路线:1 步
反应条件:
参考文献:
Total synthesis of (+)-rutamarin
Zhang, Yi-Nan; Zhang, Shi-Lei; Ma, Lei; Zhang, Yu; Shen, Xu; et al, Advanced Synthesis & Catalysis, 2008, 350, 2373-2379
合成路线:1 步
反应条件:
参考文献:
Inhibitors of DNA polymerase β: Activity and mechanism
Gao, Zhijie; Maloney, David J.; Dedkova, Larisa M.; Hecht, Sidney M., Bioorganic & Medicinal Chemistry, 2008, 16(8), 4331-4340
合成路线:1 步
反应条件:
参考文献:
Total Synthesis of Caesalpinnone A
Liu, Zhigang; Meng, Yifei; Yuan, Pengrui; Wang, Zhengshen; Gao, Jin-Ming ; et al, Organic Letters, 2020, 22(2), 520-522
合成路线:1 步
反应条件:
参考文献:
Preparation of [(biphenylyl)butenynyl]benzoates and analogs as retinoid receptor ligands
, European Patent Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis and biological activity of flavane derivatives
He, Lan; Kong, E-Jing; Liu, Yu-Mei; An, Yu; Zhang, Wen-Sheng; et al, Chinese Journal of Chemistry, 2006, 24(3), 401-408
合成路线:1 步
反应条件:
参考文献:
A chiral pool approach for asymmetric syntheses of both antipodes of equol and sativan
Yalamanchili, Chinni; Chittiboyina, Amar G.; Chandra Kumar Rotte, Sateesh; Katzenellenbogen, John A.; Helferich, William G.; et al, Tetrahedron, 2018, 74(16), 2020-2029
合成路线:1 步
反应条件:
参考文献:
Biomimetic Syntheses and Antiproliferative Activities of Racemic, Natural (-), and Unnatural (+) Glyceollin I
Khupse, Rahul S.; Sarver, Jeffrey G.; Trendel, Jill A.; Bearss, Nicole R.; Reese, Michael D.; et al, Journal of Medicinal Chemistry, 2011, 54(10), 3506-3523
合成路线:1 步
反应条件:
参考文献:
Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-γ activators
Bhattarai, Bharat Raj; Kafle, Bhooshan; Hwang, Ji-Sun; Ham, Seung Wook; Lee, Keun-Hyeung; et al, Bioorganic & Medicinal Chemistry Letters, 2010, 20(22), 6758-6763
合成路线:1 步
反应条件:
参考文献:
N-Containing chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus infection and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of O-lactam substituted phenyl ethers as hemoglobin modulators
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Glucosylated near-infrared dye suitable for visualization targeted drug delivery
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Design and synthesis of 3,3'-biscoumarin-based c-Met inhibitors
Xu, Jimin; Ai, Jing; Liu, Sheng; Peng, Xia; Yu, Linqian; et al, Organic & Biomolecular Chemistry, 2014, 12(22), 3721-3734
合成路线:1 步
反应条件:
参考文献:
Stable pharmaceutical compositions of pegylated carfilzomib compounds
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pegylated carfilzomib compounds and prodrugs, their pharmaceutical compositions and methods and uses for treating cancers
, World Intellectual Property Organization, , ,

2-羟基-4-(甲氧基甲氧基)苯甲醛(95332-26-6)相关文献